Expanding the feasibility of nephron-sparing surgery: time for a paradigm shift?

BJU Int. 2019 May;123(5):746-748. doi: 10.1111/bju.14657.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Axitinib*
  • Feasibility Studies
  • Humans
  • Kidney Neoplasms / surgery*
  • Nephrectomy
  • Nephrons

Substances

  • Axitinib